StonvexLoading…
StonvexStonvexStonvexCore line items from CSBB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $57.04M | $51.60M | $46.02M | $34.82M |
Operating Income | $16.56M | $12.34M | $18.38M | $16.54M |
Net Income | $13.36M | $10.01M | $14.76M | $13.31M |
EPS (Diluted) | $5.07 | $3.76 | $5.51 | $4.91 |
Total Assets | $1.29B | $1.19B | $1.18B | $1.16B |
Total Liabilities | $1.17B | $1.08B | $1.07B | $1.06B |
Cash & Equivalents | $99.31M | $73.51M | $64.08M | $86.42M |
Free Cash Flow OCF − CapEx | $19.08M | $13.71M | $15.20M | $14.03M |
Shares Outstanding | 2.63M | 2.65M | 2.67M | 2.71M |